About Alon Lazarus
Form D filings for Bluejay Therapeutics from 2022 to 2024 list Alon Lazarus as director.
Alon Lazarus first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Alon Lazarus in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Alon Lazarus works with at each company, as listed on that company's latest Form D.
Bluejay Therapeutics, Inc. · Form D, May 10, 2024
DE
Dan Estes
Director
PK
Pascal Krotee
Director
JL
Jianqing Li
Director
KC
Keting Chu
Chief Executive Officer and director
DY
Dajun Yang
Director